PT94030A - Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella - Google Patents

Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella

Info

Publication number: PT94030A
Authority: PT; Portugal
Prior art keywords: preparation; toxic effects; protective against; against bordetella; antigen protective
Prior art date: 1989-05-12

Application number

PT94030A

Other languages

English (en)

Other versions

PT94030B (pt

Inventor

Nicole Guiso-Maclouf

Original Assignee

Pasteur Institut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-12

Filing date

1990-05-14

Publication date

1991-01-08

1990-05-14 Application filed by Pasteur Institut filed Critical Pasteur Institut

1991-01-08 Publication of PT94030A publication Critical patent/PT94030A/pt

1997-07-31 Publication of PT94030B publication Critical patent/PT94030B/pt

Links

238000000034 method Methods 0.000 title abstract 3
238000002360 preparation method Methods 0.000 title abstract 3
208000018150 Bordetella infection Diseases 0.000 title 1
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000001681 protective effect Effects 0.000 title 1
231100000331 toxic Toxicity 0.000 title 1
230000002588 toxic effect Effects 0.000 title 1
241000588807 Bordetella Species 0.000 abstract 3
241000124008 Mammalia Species 0.000 abstract 2
102000030621 adenylate cyclase Human genes 0.000 abstract 2
108060000200 adenylate cyclase Proteins 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
230000003053 immunization Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT94030A 1989-05-12 1990-05-14 Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella PT94030B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8906321A FR2646776B1 (fr)	1989-05-12	1989-05-12	Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella

Publications (2)

Publication Number	Publication Date
PT94030A true PT94030A (pt)	1991-01-08
PT94030B PT94030B (pt)	1997-07-31

Family

ID=9381646

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT94030A PT94030B (pt)	1989-05-12	1990-05-14	Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella

Country Status (10)

Country	Link
US (3)	US6214356B1 (pt)
EP (1)	EP0424518B1 (pt)
JP (1)	JP3399525B2 (pt)
AT (1)	ATE115861T1 (pt)
CA (1)	CA2033085C (pt)
DE (1)	DE69015314T2 (pt)
ES (1)	ES2066206T3 (pt)
FR (1)	FR2646776B1 (pt)
PT (1)	PT94030B (pt)
WO (1)	WO1990013312A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2646776B1 (fr)	1989-05-12	1994-06-03	Pasteur Institut	Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) *	1994-12-15	1996-06-21	Pasteur Institut	Vaccin de type acellulaire anti-bordetella
US6030625A (en) *	1994-12-15	2000-02-29	Institut Pasteur	Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (fr)	1995-06-30	1997-09-05	Pasteur Institut	Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
US7462472B2 (en) *	2001-11-02	2008-12-09	The University Of Chicago	Methods and compositions relating to anthrax pathogenesis
AU2004277342B2 (en)	2003-10-02	2010-12-16	Glaxosmithkline Biologicals S.A.	Pertussis antigens and use thereof in vaccination
US7521059B2 (en) *	2004-06-14	2009-04-21	Fenwick Bradley W	Kennel cough vaccine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8412207D0 (en) *	1984-05-12	1984-06-20	Wellcome Found	Antigenic preparations
US5237052A (en)	1984-05-12	1993-08-17	Burroughs Wellcome Company	Antigenic preparations and isolation of such preparations
US4652521A (en) *	1985-03-04	1987-03-24	Regents Of The University Of Minnesota	Method for the early diagnosis of bordetella diseases and kit therefor
FR2590483B1 (fr) *	1985-11-22	1988-12-09	Pasteur Institut	Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
EP0267998A1 (en) *	1986-11-17	1988-05-25	Institut Pasteur	Means for protecting against bordetella infections and toxic processes
FR2606789B1 (fr) *	1986-11-17	1991-05-31	Pasteur Institut	Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
FR2621597B1 (fr)	1987-07-24	1992-07-31	Pasteur Institut	Procede de clonage et d'expression de genes codant pour des proteines constituant des edifices fonctionnels organises
ES2091186T3 (es) *	1988-04-19	1996-11-01	Pasteur Institut	Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella.
EP0338170A1 (en) *	1988-04-19	1989-10-25	Institut Pasteur	Immunoprotective antigenic protein against pathogenic bacteria
FR2638169B1 (fr) *	1988-10-25	1991-01-11	Pasteur Institut	Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) *	1989-05-12	1994-06-03	Pasteur Institut	Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
DK0425082T3 (da) *	1989-09-04	1995-07-03	Evans Medical Ltd	Vacciner
US5786189A (en) *	1989-11-29	1998-07-28	Smithkline Beecham Biologicals (S.A.)	Vaccine
DE69333467T2 (de) *	1992-08-18	2005-01-20	Dimminaco Ag	Bordetella bronchiseptica impfstoff
US6030625A (en) *	1994-12-15	2000-02-29	Institut Pasteur	Bordetella pertussis and Bordetella parapertussis strains
FR2728170A1 (fr) *	1994-12-15	1996-06-21	Pasteur Institut	Vaccin de type acellulaire anti-bordetella
PT826001E (pt) *	1995-05-04	2002-12-31	Aventis Pasteur	Vacinas acelulares contra a tosse convulsa e metodos para a sua preparacao
FR2736064B1 (fr) *	1995-06-30	1997-09-05	Pasteur Institut	Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
GB9718901D0 (en) *	1997-09-05	1997-11-12	Smithkline Beecham Biolog	Vaccine
ATE393166T1 (de) *	2000-05-25	2008-05-15	Pasteur Institut	Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
PT1188446E (pt)	2000-09-15	2009-11-10	Pasteur Institut	Vectores proteinácios para a distribuição da molécula a células que expressam cd11b

1989
- 1989-05-12 FR FR8906321A patent/FR2646776B1/fr not_active Expired - Lifetime
1990
- 1990-05-11 JP JP50797590A patent/JP3399525B2/ja not_active Expired - Lifetime
- 1990-05-11 EP EP90908234A patent/EP0424518B1/fr not_active Expired - Lifetime
- 1990-05-11 DE DE69015314T patent/DE69015314T2/de not_active Expired - Lifetime
- 1990-05-11 ES ES90908234T patent/ES2066206T3/es not_active Expired - Lifetime
- 1990-05-11 AT AT90908234T patent/ATE115861T1/de not_active IP Right Cessation
- 1990-05-11 CA CA002033085A patent/CA2033085C/fr not_active Expired - Lifetime
- 1990-05-11 WO PCT/FR1990/000337 patent/WO1990013312A1/fr not_active Ceased
- 1990-05-14 PT PT94030A patent/PT94030B/pt not_active IP Right Cessation
1992
- 1992-08-07 US US07/926,021 patent/US6214356B1/en not_active Expired - Fee Related
2001
- 2001-01-30 US US09/771,599 patent/US20020172691A1/en not_active Abandoned
2003
- 2003-01-02 US US10/334,796 patent/US7211263B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6214356B1 (en)	2001-04-10
FR2646776A1 (fr)	1990-11-16
CA2033085C (fr)	2003-07-22
FR2646776B1 (fr)	1994-06-03
US7211263B2 (en)	2007-05-01
DE69015314T2 (de)	1996-11-28
ATE115861T1 (de)	1995-01-15
US20020172691A1 (en)	2002-11-21
WO1990013312A1 (fr)	1990-11-15
DE69015314D1 (de)	1995-02-02
CA2033085A1 (fr)	1990-11-13
PT94030B (pt)	1997-07-31
JPH03506044A (ja)	1991-12-26
EP0424518A1 (fr)	1991-05-02
JP3399525B2 (ja)	2003-04-21
EP0424518B1 (fr)	1994-12-21
ES2066206T3 (es)	1995-03-01
US20030224003A1 (en)	2003-12-04

Legal Events

Date

Code

Title

Description

1997-07-31

FG3A

Patent granted, date of granting

Effective date: 19970506

2012-05-14

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120507

Publication	Publication Date	Title
DK0754055T3 (da)	2000-12-18	Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder
EP1170016A3 (en)	2002-03-06	Urease-based vaccine against helicobacter infection
EP0835315A4 (en)	2001-09-05	VACCINE AGAINST THE VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTION DISEASES IN PIGS
LU91610I2 (fr)	2009-11-24	Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
UA40597C2 (uk)	2001-08-15	Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
DE69331758D1 (de)	2002-05-02	Fibrinogen-bildungsprotein
ES2104535T1 (es)	1997-10-16	Vacuna que contiene proteina de membrana externa de bordetella pertussis, y metodo para elaborar tal vacuna.
ES2100240T3 (es)	1997-06-16	Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
NO950483L (no)	1995-04-07	Vaksine mot hepatitt-A
WO1994010317A3 (en)	1994-07-07	Conjugate vaccine against group b streptococcus
WO2002092131A3 (en)	2003-03-20	Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
DE69015314D1 (de)	1995-02-02	Verwendung von adenylzyclase als vakzin gegen bordetella.
EP0161095A3 (en)	1987-06-03	Vaccine against urinary infection
PT99923A (pt)	1992-12-31	Processo para a preparacao de proteinas hibridas de plasmodium falciparum que contem sequencias dos antigenios da malaria hrpii e serp e de composicoes farmaceuticas que contem estas proteinas
Panse et al.	1964	Passive immunity in experimental cholera
ATE111485T1 (de)	1994-09-15	Peptidbehandlung von hartnäckigen infektionskrankheiten.
Puentes et al.	1993	Efficacy of Various Non‐Oily Adjuvants in Immunization Against the Aujeszky's Disease (Pseudorabies) Virus
ATE439857T1 (de)	2009-09-15	Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen
RU2005133709A (ru)	2006-05-10	Холестеринсодержащие соединения и их применение в качестве иммуногенов против borrelia burgdorferi
NO934547L (no)	1994-02-10	Oral behandling av Helicobacter-infeksjon
MY104932A (en)	1994-07-30	Immunomodulatory azaspiranes
WO2003040163B1 (en)	2004-03-25	Immunomodulating saponins, a method for their preparation and their use for vaccines